Medicine and Dentistry
Parkinson's Disease
63%
Parkinsonism
20%
Clinical Research
18%
White Population
18%
Symptom Assessment
18%
Vitamin B12
18%
Vitamin B12 Deficiency
10%
Public Health
9%
Research Participation
9%
Drive
9%
Gut
9%
Quality of Life
9%
Dopamine Agonist
9%
Side Effect
9%
Physical Disease by Body Function
9%
Impulse Control Disorder
9%
Comorbidity
9%
Diseases
9%
Pandemic
9%
Levodopa
7%
Pramipexole
6%
Rapid Eye Movement Behavior Disorder
6%
Biological Marker
6%
Somnolence
6%
Polysomnography
6%
Brain Scintiscanning
6%
Ropinirole
6%
Lifestyle Modification
6%
Neuromelanin
6%
Sleep Disorder
6%
Magnetic Resonance Imaging
6%
Excessive Daytime Sleepiness
6%
Pathophysiology
5%
Supplementation
5%
Neuroscience
Parkinson's Disease
100%
Sleep Disorder
27%
Parkinsonism
26%
Non-Motor Symptoms
21%
Cyanocobalamin
18%
SARS Coronavirus
18%
Coronavirus
14%
Coronavirinae
14%
Serotonergic
12%
L-DOPA
9%
Dopamine Agonist
9%
Impulse Control Disorder
9%
Comorbidity
9%
Agonist
6%
Cholinergic
6%
Ropinirole
6%
Somnolence
6%
Polysomnography
6%
Daytime Somnolence
6%
Magnetic Resonance Imaging of Brain
6%
Rapid Eye Movement Sleep
6%
Behavior Disorder
6%
Neuromelanin
6%
Pramipexole
6%
Dysautonomia
5%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
72%
Sleep Disorder
24%
SARS Coronavirus
18%
Vitamin B12
18%
Diseases
14%
Coronavirinae
14%
Levodopa
11%
Cyanocobalamin Deficiency
10%
Parkinsonism
8%
Dopamine Receptor Stimulating Agent
7%
Pathophysiology
7%
Infection
6%
Neuromelanin
6%
Behavior Disorder
6%
Cholinergic Receptor Stimulating Agent
6%
Somnolence
6%
Ropinirole
6%
Daytime Somnolence
6%
Pramipexole
6%
Biological Marker
6%
